Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis

International Journal of Mycobacteriology
Giovanni SotgiuG B Migliori

Abstract

Tuberculosis represents an important clinical and public health problem globally, particularly in low- and middle-income countries. During the last 20 years, two relevant events has changed the epidemiology of the disease: the spread of the TB/HIV co-infection and the emergence and spread of the multi-drug resistance tuberculosis (i.e., tuberculosis caused by strains resistant to at least isoniazid and rifampicin). The latter phenomenon has been generated by the inappropriate management of the anti-tuberculosis drugs. Currently, the World Health Organization estimates at least 600,000 MDR-TB cases worldwide, particularly in China, India, South Africa, and in former Soviet Union countries. Unfortunately, new difficult-to-treat MDR-TB cases have been described, named XDR- or TDR-TB (extensively or totally drug-resistant tuberculosis, respectively). Numerous observational retrospective studies proved the poorer prognostic profile of the MDR-TB cases when compared with drug-susceptible tuberculosis. The clinical management of the patients with an XDR and beyond pattern is complicated owing to the poorest, expensive, and toxic therapeutic options. MDR-TB is currently under-reported because of methodological issues, mainly related to...Continue Reading

References

May 18, 2000·JAMA : the Journal of the American Medical Association·M A EspinalM C Raviglione
Aug 11, 2007·The European Respiratory Journal·G B MiglioriUNKNOWN SMIRA/TBNET Study Group
Feb 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Giovanni Battista MiglioriUNKNOWN SMIRA/TBNET Study Group
Aug 14, 2008·The Journal of Antimicrobial Chemotherapy·P M Hawkey
Nov 28, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherJohn Bartlett
Feb 28, 2009·The Lancet Infectious Diseases·Evan W OrensteinAlison P Galvani
Mar 3, 2009·The European Respiratory Journal·G SotgiuG B Migliori
Aug 19, 2009·The Journal of Antimicrobial Chemotherapy·Peter M Hawkey, Annie M Jones
Nov 3, 2009·The European Respiratory Journal·A A VelayatiM Varahram
Oct 12, 2010·The European Respiratory Journal·G B MiglioriR Centis
May 3, 2011·The European Respiratory Journal·M C RaviglioneG B Migliori
Aug 11, 2011·The European Respiratory Journal·D FalzonM Zignol
Oct 19, 2011·The European Respiratory Journal·Marieke J van der WerfDavide Manissero
Oct 19, 2011·The European Respiratory Journal·M W LangendamD Manissero
Oct 19, 2011·The European Respiratory Journal·Alena SkrahinaMatteo Zignol
Dec 23, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Zarir F UdwadiaCamilla Rodrigues
Jun 2, 2012·The European Respiratory Journal·Giovanni Battista MiglioriMarieke J van der Werf
Jun 2, 2012·The European Respiratory Journal·Giovanni Battista MiglioriMario C Raviglione
Jul 26, 2012·Lancet·Giovanni Battista Migliori, Giovanni Sotgiu
Sep 22, 2012·The European Respiratory Journal·Saverio De LorenzoGiovanni Battista Migliori
Sep 29, 2012·The European Respiratory Journal·Vija SkripconokaCharles D Wells
Nov 28, 2012·Indian Journal of Medical Microbiology·R ChoudhuryD V Singh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Cold Spring Harbor Perspectives in Medicine
Giovanni SotgiuG B Migliori
Future Microbiology
Giovanna Poce, Mariangela Biava
Pulmonary Pharmacology & Therapeutics
Giovanni Sotgiu, G B Migliori
Seminars in Respiratory and Critical Care Medicine
Charles L Daley, Jose A Caminero
Enfermedades infecciosas y microbiología clínica
Fernando Alcaide, Miguel Santín
© 2022 Meta ULC. All rights reserved